Cargando…
Histamine-Releasing Factor, a New Therapeutic Target in Allergic Diseases
Histamine-releasing activities on human basophils have been studied as potential allergy-causing agents for four decades. An IgE-dependent histamine-releasing factor (HRF) was recently shown to interact with a subset of immunoglobulins. Peptides or recombinant proteins that block the interactions be...
Autores principales: | Kawakami, Yu, Kasakura, Kazumi, Kawakami, Toshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952944/ https://www.ncbi.nlm.nih.gov/pubmed/31779161 http://dx.doi.org/10.3390/cells8121515 |
Ejemplares similares
-
Histamine-Releasing Factor and Immunoglobulins in Asthma and Allergy
por: Kawakami, Toshiaki, et al.
Publicado: (2014) -
Recent advances in mast cell activation and regulation
por: Kim, Hwan Soo, et al.
Publicado: (2020) -
Immunoglobulin E-Dependent Activation of Immune Cells in Rhinovirus-Induced Asthma Exacerbation
por: Kawakami, Toshiaki, et al.
Publicado: (2022) -
Regulation of Syk activity by antiviral adaptor MAVS in FcεRI signaling pathway
por: Kawakami, Yuko, et al.
Publicado: (2023) -
Potential role of histamine releasing factor (HRF) as a therapeutic target for treating asthma and allergy
por: MacDonald, Susan M
Publicado: (2012)